Lenskart in talks for 200 million infusion from Temasek, Fidelity, eyeing $5 billion valuation

Lenskart in talks for 200 million infusion from Temasek, Fidelity, eyeing $5 billion valuation
Mint
Published onMint
Publish Date25 April 2024
Reading time1 Min

Share on Social Links

Category

StockBeginner GuideAngel InvestingSME IPOEconomy MarketAIFInvestmentsMore

Lenskart is engaged in talks with Temasek and Fidelity for a $200 million funds infusion through a secondary share sale, The Economic Times reported citing sources.


A significant increase from its previous valuation, this move would also place Lenskart's worth at over three times that of competitor Warby Parker, the report added. A New York-based online eyewear retailer, Warby Parker went public on the NYSE in 2022 with a market cap of close to $1.55 billion.

Tags

StockBeginner GuideAngel InvestingSME IPOEconomy MarketAIFInvestmentsMore

Stay Connected, Stay Informed –

Join Our

WhatsApp

Channel!

Don’t miss out on exclusive updates, market trends, and real-time investment opportunities. Be the first to know about the latest unlisted stocks, IPO announcements, and curated Fact Sheets, delivered straight to your WhatsApp.

Pre Ipo

Pre Ipo

Upcoming IPO

Upcoming IPO

Unicorn

Unicorn